BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’

  TriLink BioTechnologies®, a Maravai LifeSciences company and global provider of life science reagents and services, has launched its Analytical Sciences Center of Excellence hub.

  November 2, 2023

   · 

  6 min read
• Pharm Country

  Applied Therapeutics to Present at the UBS Biopharma Conference 2023

  Applied Therapeutics, Inc. announced that it will present at the UBS Biopharma Conference 2023 on Thursday, November 9, 2023 at 2:00 p.m. ET in Miami, Florida.

  November 2, 2023

   · 

  1 min read
• Business

  InMode Reports Third Quarter 2023 Financial Results; Quarterly Revenue of $123.1M Represents 2% Year-Over-Year Growth

  InMode Ltd., a leading global provider of innovative medical technologies, announced its consolidated financial results for the third quarter ended September 30, 2023.

  November 2, 2023

   · 

  16 min read
• Drug Development

  Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection

  Acurx Pharmaceuticals, Inc. announced efficacy results from the Phase 2 clinical trial of ibezapolstat for the treatment of C. difficile Infection.

  November 2, 2023

   · 

  15 min read
• Business

  Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023

  Exscientia plc will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. markets.

  November 2, 2023

   · 

  1 min read
• Business

  Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day

  Bicycle Therapeutics plc reported financial results for the third quarter ended September 30, 2023, and provided recent corporate updates.

  November 2, 2023

   · 

  11 min read
• Business

  AlloVir Reports Third Quarter 2023 Financial Results

  AlloVir, Inc., a late-clinical stage allogeneic T cell immunotherapy company, reported financial results from the third quarter ended September 30, 2023.

  November 2, 2023

   · 

  9 min read
• Pharm Country

  Sun Pharma Survey Reveals Americans with Mild-to-Moderate Acne Have Defeatist Attitudes About Treatment, Despite Self-Consciousness

  Sun Pharmaceutical Industries, Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited, released results of a survey revealing defeatist attitudes about treatment among people with mild-to-moderate acne, despite feelings of self-consciousness.

  November 2, 2023

   · 

  4 min read
• Drug Development

  Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells at the 2023 ASH Annual Meeting

  Affimed N.V. announced two upcoming presentations on its lead innate cell engager AFM13 at the American Society of Hematology 2023 Annual Meeting.

  November 2, 2023

   · 

  9 min read
• Press Releases

  Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting

  Sana Biotechnology, Inc., a company focused on changing the possible for patients through engineered cells, announced that five abstracts will have poster presentations at the 65th American Society of Hematology Annual Meeting to be held December 9-12, 2023 in San Diego, CA.

  November 2, 2023

   · 

  4 min read